Published in Behav Brain Funct on January 17, 2008
Comprehensive behavioral analysis of calcium/calmodulin-dependent protein kinase IV knockout mice. PLoS One (2010) 0.98
Comprehensive behavioral phenotyping of ryanodine receptor type 3 (RyR3) knockout mice: decreased social contact duration in two social interaction tests. Front Behav Neurosci (2009) 0.92
Retracted Blockade of protein phosphatase 2B activity in the amygdala increases anxiety- and depression-like behaviors in mice. Biol Psychiatry (2009) 0.79
The Emerging Roles of the Calcineurin-Nuclear Factor of Activated T-Lymphocytes Pathway in Nervous System Functions and Diseases. J Aging Res (2016) 0.78
Family-based association study of early growth response gene 3 with child bipolar I disorder. J Affect Disord (2012) 0.78
Inhibition of calcineurin by FK506 stimulates germinal vesicle breakdown of mouse oocytes in hypoxanthine-supplemented medium. PeerJ (2017) 0.75
Variation in PPP3CC Genotype Is Associated with Long-Term Recovery after Severe Brain Injury. J Neurotrauma (2016) 0.75
Calcineurin downregulation in the amygdala is sufficient to induce anxiety-like and depression-like behaviors in C57BL/6J male mice. Biol Psychiatry (2014) 0.75
MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science (2002) 6.29
Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet (2003) 5.16
Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell (2001) 3.55
Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci U S A (2003) 2.62
The role of calmodulin as a signal integrator for synaptic plasticity. Nat Rev Neurosci (2005) 2.25
Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry (2004) 1.76
Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci U S A (2003) 1.54
Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol Psychiatry (2004) 1.46
Antipsychotic drug treatment induces differential gene expression in the rat cortex. J Neurochem (2002) 1.14
Signal transduction and genes-to-behaviors pathways in psychiatric diseases. Sci STKE (2003) 1.06
Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia. Biol Psychiatry (2005) 0.97
A general asymptotic property of two-locus selection models. Theor Popul Biol (1988) 0.94
Changes in calcineurin expression induced in the rat brain by the administration of antipsychotics. J Neurochem (2005) 0.84
Calcineurin (protein phosphatase 2B) is involved in the mechanisms of action of antidepressants. Neuroscience (2007) 0.84
Association analysis of adenylate cyclase type 9 gene using pedigree disequilibrium test in bipolar disorder. Mol Psychiatry (2002) 0.82
No association with the calcineurin A gamma subunit gene (PPP3CC) haplotype to Japanese schizophrenia. J Neural Transm (Vienna) (2005) 0.81
Postmortem brain calcineurin protein levels in schizophrenia patients are not different from controls. Schizophr Res (2006) 0.79
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet (2003) 15.31
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet (2006) 11.14
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol (2002) 4.82
Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci U S A (2010) 4.02
A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42
Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet (2011) 2.71
A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci (2002) 2.71
Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet (2012) 2.65
Diverse psychotomimetics act through a common signaling pathway. Science (2003) 2.52
Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46
Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology (Berl) (2014) 2.37
Impaired decision making in suicide attempters. Am J Psychiatry (2005) 2.37
Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet (2010) 2.14
Abnormal cortical voice processing in autism. Nat Neurosci (2004) 2.11
Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry (2009) 2.03
Longitudinal studies of cognition in schizophrenia: meta-analysis. Br J Psychiatry (2008) 1.89
Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study. Lancet (2008) 1.73
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
ROAMER: roadmap for mental health research in Europe. Int J Methods Psychiatr Res (2014) 1.67
Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice. Am J Hum Genet (2008) 1.65
Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet (2007) 1.65
SHANK1 Deletions in Males with Autism Spectrum Disorder. Am J Hum Genet (2012) 1.59
The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nat Neurosci (2008) 1.57
Zebrafish atlastin controls motility and spinal motor axon architecture via inhibition of the BMP pathway. Nat Neurosci (2010) 1.52
Paradoxical increase in survival of newborn neurons in the dentate gyrus of mice with constitutive depletion of serotonin. Eur J Neurosci (2013) 1.49
Loss of X-linked mental retardation gene oligophrenin1 in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity. J Neurosci (2007) 1.48
Fronto-striatal overactivation in euthymic bipolar patients during an emotional go/nogo task. Am J Psychiatry (2007) 1.45
L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor. J Neurosci (2012) 1.43
Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry (2013) 1.43
A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet (2011) 1.43
Age at onset in bipolar affective disorders: a review. Bipolar Disord (2005) 1.42
Conscious and subliminal conflicts in normal subjects and patients with schizophrenia: the role of the anterior cingulate. Proc Natl Acad Sci U S A (2003) 1.36
Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci (2014) 1.34
Age at onset in bipolar I affective disorder: further evidence for three subgroups. Am J Psychiatry (2003) 1.33
Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders. Biol Psychiatry (2009) 1.32
Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology (2006) 1.30
FtsK-dependent dimer resolution on multiple chromosomes in the pathogen Vibrio cholerae. PLoS Genet (2008) 1.30
VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. J Neurosci (2010) 1.29
Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proc Natl Acad Sci U S A (2002) 1.28
Four-factor structure of obsessive-compulsive disorder symptoms in children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry (2008) 1.28
Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2007) 1.27
Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. Psychiatry Res (2004) 1.27
Neuroimaging-based markers of bipolar disorder: evidence from two meta-analyses. J Affect Disord (2011) 1.25
Progress toward treatments for synaptic defects in autism. Nat Med (2013) 1.24
Expression and genetic variability of PCDH11Y, a gene specific to Homo sapiens and candidate for susceptibility to psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet (2006) 1.24
Admixture analysis of age at first suicide attempt. J Psychiatr Res (2009) 1.20
Cortical folding abnormalities in schizophrenia patients with resistant auditory hallucinations. Neuroimage (2007) 1.20
Delayed activation of Xer recombination at dif by FtsK during septum assembly in Escherichia coli. Mol Microbiol (2008) 1.18
OPA1 R445H mutation in optic atrophy associated with sensorineural deafness. Ann Neurol (2005) 1.18
Immunological and autoimmune considerations of Autism Spectrum Disorders. J Autoimmun (2013) 1.17
Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci (2012) 1.13
Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry (2013) 1.12
Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry (2003) 1.11
Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background. Eur J Neurosci (2004) 1.11
Tests of executive functions in first-degree relatives of schizophrenic patients: a meta-analysis. Psychol Med (2005) 1.11
Beyond genetics: childhood affective trauma in bipolar disorder. Bipolar Disord (2008) 1.11
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Affective lability and affect intensity as core dimensions of bipolar disorders during euthymic period. Psychiatry Res (2008) 1.10
A meta-analysis of whole-brain diffusion tensor imaging studies in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2011) 1.09
A mechanistic basis for amplification differences between samples and between genome regions. BMC Genomics (2012) 1.06
Faux pas detection and intentional action in Asperger Syndrome. A replication on a French sample. J Autism Dev Disord (2008) 1.06
Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci (2004) 1.06
Treatment nonadherence and neurocognitive impairment in bipolar disorder. J Clin Psychiatry (2009) 1.05
Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. J Neurochem (2008) 1.05
Population-based and family-based association study of 5'UTR polymorphism of the reelin gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2005) 1.05
Early-onset obsessive-compulsive disorder: a subgroup with a specific clinical and familial pattern? J Child Psychol Psychiatry (2005) 1.04
Morphometric characterization of microglial phenotypes in human cerebral cortex. J Neuroinflammation (2014) 1.04
Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am J Med Genet (2002) 1.04
Shared executive dysfunctions in unaffected relatives of patients with autism and obsessive-compulsive disorder. Eur Psychiatry (2006) 1.04
Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody. J Clin Invest (2006) 1.04
Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences. Neuropsychopharmacology (2011) 1.03
The promise of biological markers for treatment response in first-episode psychosis: a systematic review. Schizophr Bull (2015) 1.03
Prefrontal cortex dysfunction in patients with suicidal behavior. Psychol Med (2006) 1.03
Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. J Neurosci (2005) 1.02
Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study. Int J Neuropsychopharmacol (2009) 1.02
Immuno- inflammatory markers of bipolar disorder: a review of evidence. Front Biosci (Elite Ed) (2012) 1.02
A genetic family-based association study of OLIG2 in obsessive-compulsive disorder. Arch Gen Psychiatry (2007) 1.02
A first national survey of knowledge, attitudes and behaviours towards schizophrenia, bipolar disorders and autism in France. BMC Psychiatry (2012) 1.02
Developmentally regulated expression of VGLUT3 during early post-natal life. Neuropharmacology (2005) 1.01
DARPP-32 mediates serotonergic neurotransmission in the forebrain. Proc Natl Acad Sci U S A (2002) 1.01
Microtubule-associated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission. J Neurochem (2008) 1.00